Taconic Biosciences News

Critical Jh Syngeneic Tumor Model Host Now Available on a B6 Background Rensselaer, NY — January 18, 2021 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an expansion of its immuno-oncology portfolio. Immuno-oncology is a leading research priority because it uses the body's own immune system to effectively treat some types of cancer. Syngeneic tumor animal models play a critical role...  Read More

The Holiday Season, while often a joyous time of year, can also be a very stressful time of year for many individuals and families. To add to this a global pandemic, the Holiday Season of 2020 left several people in various forms of need, whether that be emotionally, financially, or both. The Quality Department at Taconic Biosciences found a way to spread some holiday cheer, enriching people's...  Read More

New Random Integration Transgenic Animal Model Generation Solution Available Rensselaer, NY — December 3, 2020 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the new ExpressMODEL®: Random Integration Transgenic (RITg) service, which reduces animal model generation costs and timeline. Many gene editing technologies are used to generate animal models for drug discovery, each with unique considerations but with...  Read More

Immediate availability of hACE2 mouse Rensselaer, NY — October 26, 2020 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces immediate humanized ACE2 mouse model availability for COVID-19 research. The SARS-CoV-2 virus, which causes COVID-19, uses the ACE2 receptor to enter cells. Due to differences between the mouse and human ACE2 receptors, normal laboratory mice cannot be infected with SARS-CoV2. Transgenic mice...  Read More

On September 2nd 2020, Taconic Biosciences hosted a 2nd blood drive in honor of a former colleague, with 24 units of blood were collected. The American Red Cross reports that every 2 seconds someone needs blood administered. A single blood donation can save up to 3 lives, and saved the life of our former colleague who needed 8 units during a recovery. Many thanks to our employees...  Read More

Research into COVID-19 is rapidly evolving, and Taconic Biosciences' Dr. Megan MacBride explains in a recent article in Drug Discovery News how mouse models will enable researchers to move forward with SARS-CoV-2 research. She also provides examples of several genetically-engineered mouse models that were previously developed to study SARS, a closely-related coronavirus, may be viable candidates for studying COVID-19 viral infection: "The CRISPR/Cas9 system, and variants of...  Read More

In a recent article published in Drug Discovery News, Taconic's Dr. Terina Martinez explains how behavior is influenced by multiple molecular pathways. She goes on to note that studies that aim to explore behavioral observations must be carefully designed and researchers should be very thoughtful in the interpretation of results. As a first step towards advancing neuroscience studies in humans, researchers should first conduct their studies in...  Read More

Non-alcoholic fatty liver disease (NAFLD) is a growing concern for clinicians and researchers, alike. One key problem with understanding how widespread this disease is, as it usually develops slowly and without symptoms. In a recent article for Drug Discovery News (DDN), Taconic's Field Applications Scientist Dr. Janell Richardson described how mouse models are helping advance research in this field. While no one model is perfect for modeling...  Read More

The microbiome is increasingly cited as a key regulator of health and disease. This article published in Lab Animal highlights the role of differing microbiomes from different animal model vendors, as well as the importance of maintaining a consistent microbiome to increase reproducibility. As mentioned, Taconic's TruBIOME® solution enables researchers to develop a specific microbiota and maintain it for multiple generations of breeding. Read more here...  Read More

Pharma Tech Outlook recently featured Taconic Biosciences as a top microbiome solutions provider in 2020. Dr. Alexander Maue, a Scientific Program Manager at Taconic with extensive experience in immunology and germ-free mice, was featured in this article to comment on evolving research into the microbiome of mouse models. He specifically highlights the growing microbiota repository, which enables researchers to select a specific microbiome for association with their...  Read More